Professor Claudia Nold, NHMRC Leadership Fellow
Inflammatory diseases in vulnerable newborns can be life-threatening, and those who survive often face lifelong health problems. By investigating how harmful inflammation takes hold in newborns, my goal is to discover new therapies that save lives and improve life-long health.
Areas of interest
Professor Claudia Nold is a world-renowned inflammation and cytokine biology expert. Her research interest is on inflammation and anti-inflammatory treatments, with a focus in newborn. She has established a translational research pipeline that encompasses fundamental immunology through to clinical trials.
Prof Nold’s work includes the discovery of anti-inflammatory drug targets and the development biologics with enhanced anti-inflammatory properties. These will ultimately be used to develop of new immunotherapeutics for a range of inflammatory diseases.
Prof Nold’s research focus is on discovering the mechanisms of inflammatory diseases, with a particular emphasis on
- Preterm disease including diseases of the cardiac and pulmonary systems – bronchopulmonary dysplasia (BPD), pulmonary hypertension related to BPD (pulmonary hypertension-BPD), and the intestinal disease, NEC (necrotizing enterocolitis)
- Autoimmune diseases in adults, including systemic lupus erythematosus.
Prof Nold’s innovative and cross-disciplinary research programs have resulted in an investigator-initiated clinical trial, the filing of numerous patents and industry partnerships.
Her pioneering work in interventional immunological research has been recognised through many awards, including fellowships from the Australian Heart Foundation and the National Health and Medical Research Council (NHMRC) and the 2018 Monash University Vice-Chancellor’s Award for Research Enterprise.
In 2021, she was inducted into the Australian Academy of Health and Medical Sciences Mentoring Scheme.
SCIENCE TRANSLATIONAL MEDICINE
Volume 14 | Issue 639